Aim. Our aim was to study pathogenetically significant markers of sclerosing of hemangiomas in infants upon their exposure to optical radiation in the infrared region of the spectrum by morphology blood serum examination results.
Materials and methods.The basis for the thermographic study was our observation for 200 patients (birth to age 1). Diagnostic indicators of sclerosing, upon testing blood serum specimens, taken from hemangioma-affected children, were analyzed with the use of the cuneiform dehydration technique. Microscopic examination of the sampled specimen structures was performed with the LEICA DM SL2 microscope supported with original software MORPHOTEST. The data were compared with those obtained in ultrasound examinations.
Results. Structural changes in serum facies analyzed at each stage of the treatment reflected the respective alterations both in the infant organism and the malformation. Some criteria have been identified by us to indicate sclerosing of the malformation, which are as follows: wide radial cracks, incomplete concretions, Sierpinskicarpet and leaf-type structural patterns. The relevant ultrasound examination data have confirmed our suggestions that there is a reduction in hemangioma sizes, the absence of blood flow and a blood supplying blood vessel as well as regression of hemangiomas against the background of electromagnetic radiation in the optical infrared region of the spectrum.
Conclusion It has been found that the criteria for the morphology of fluids, ultrasound parameters correlate with each other and allow you to objectively assess the state and stage of development of vascular neoplasm in order to select an appropriate type of therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.